Therapeutic Vaccines
Jun 26, 2008 at 14:40
Apr 26, 2008 at 16:00
Sep 20, 2007 at 17:25
May 31, 2007 at 12:36
Photos »
/ 
Related News »
Concurrent with US Food and Drug Administration (FDA) approval of the first therapeutic cancer vaccine, a wide spectrum of other cancer vaccine platforms that target a diverse range of tumor-associated antigens is currently being evaluated in ...
May 22, 2012 at 10:09 | Source: Medscape News
Results from completed prophylactic and therapeutic studies in mice and therapeutic studies in guinea pigs included: Prophylactic pDNA vaccines encoding HSV-2 glycoprotein D (gD) alone or encoding gD and the HSV-2 tegument proteins UL46 and UL47 ...
May 16, 2012 at 10:45 | Source: msnbc.com
The new patents build on Intellect's other technology platforms, which are designed to produce therapeutic antibodies and vaccines that specifically target the earliest steps in the pathogenesis of proteinopathies. Intellect discovered that ...
May 26, 2012 at 20:20 | Source: Yahoo Finance
I am convinced that Biovest will play an important part in expanding the role of therapeutic vaccines to empower the immune system's defenses to fight cancer." The complete article (a free trial registration to Scrip Intelligence is required ...
May 21, 2012 at 23:54 | Source: Marketwatch
"Our Phase 1/2 therapeutic vaccine trial continues to enroll patients ... both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and ...
May 27, 2012 at 04:41 | Source: Yahoo Finance
... manufacturing more than 10 kinds of vaccines for humans, such as Influenza vaccine, DTaP vaccine, recombinant Hepatitis B vaccine and Hepatitis A vaccine. Kaketsuken is also developing a therapeutic monoclonal antibody for HIV, a cell-cultured ...
May 24, 2012 at 05:42 | Source: 4-traders (press release)
Chemo-Sero-Therapeutic Research Institute Kaketsuken is based in Kumamoto, Japan, has operated in the preventive medicine fields of microbiology, immunology and serology, is currently manufacturing more than 10 kinds of vaccines for humans and also ...
May 25, 2012 at 09:23 | Source: MENAFN
Bionor Pharma is a biopharmaceutical, listed company based in Oslo, Norway. The Company's investments in developing therapeutic vaccines exceed US$70 million. Bionor's vaccines are based on the proprietary technology platform developed following more than ...
May 13, 2012 at 10:13 | Source: PR-USA.net
Jennerex Announces Data Presentations Relating to Oncolytic Virus JX-594 at American Society of Clin
Transgene, a member of the Institut Merieux Group, is a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, and has five compounds in ...
May 19, 2012 at 13:55 | Source: PR-USA.net
Using a most bearish multiple of 5x, this equates to $50 a share. iBIO (IBIO) 5/10.12 pps: $1.46 IBIO engages in the development and commercialization of vaccines and therapeutic proteins through its proprietary technology, the iBioLaunch platform.
May 11, 2012 at 11:55 | Source: Seekingalpha.com